Accessibility of medicines and primary health care: The impact of the revolving drug fund in Khartoum State

African Journal of Pharmacy and Pharmacology

Volumn 3, Issue 3, 2009, Pages 070-077

  Ali, Gamal Khalafalla Mohamed ^a  

^a Public Health Institute   (Sudan)

Author keywords

Accessibility; Affordability; Availability; RDF

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; FUNDING; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HEALTH SERVICE; MEDICAL RECORD; PRIMARY HEALTH CARE;

EID: 74549193738     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Akin, JS (2000). Quality of services and demand for health care in Nigeria: a multinomial probit estimation. Social Science & Medicine 1995; 40(11):1527-1537.
2. Antezana, FS (1992). Essential medicines: action for equity. World Health; 45(2): 7-8.
3. Audibert, M Mathonnat J (2000). Cost recovery in Mauritania: initial lessons. Health Policy and Planning; 15(1): 66-75.
4. CIA. The World Fact book [online]. Available at: http://www.cia.gov/cia/ publications/factbook/geos/su.html.; 2006.
5. Diop F, Yazbeck A, Bitran R (1995). The impact of alternative cost recovery schemes on access an equity in Niger. Health Policy and Planning. 10(3): 223-240.
6. Federal Ministry of Health (2003). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan.
7. Federal Ministry of Health (1990). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan.
8. Federal Ministry of Health (1989). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan.
9. Federal Ministry of Health (1991). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan.
10. Federal Ministry of Health (1992). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan.
11. Federal Ministry of Health (1994) Annual statistical report, Federal Ministry of Health, Khartoum- Sudan.
12. Federal Ministry of Health (1996). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan;.
13. Federal Ministry of Health. Annual statistical report, Federal Ministry of Health, Khartoum- Sudan (1998).
14. Federal Ministry of Health (2000). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan;.
15. Federal Ministry of Health (2002). Annual statistical report, Federal Ministry of Health, Khartoum- Sudan.
16. Federal Ministry of Health. RBM progress in Sudan (2003). Prepared by the National Malaria Control Team. Federal Ministry of Heath, Khartoum- Sudan; 2004.
17. Gertler P, Locay L, Sanderson W (1987). Are user fees regressive? J. Econ. 36: 67-88.
18. Gilson L (2001) Strategies for promoting equity: experience with community financing in three African countries. Health Policy; 58: 37-67. (Pubitemid 32757267)
19. Gilson L, Kitange H, Teuscher T (1993). Assessment of process quality in Tanzanian primary care. Health Policy. 26: 119-139.
20. Graaff P, Everard M (2003). WHO travel report: visit to Khartoum, Sudan. World Health Organization, Geneva,.
21. Haddad S, Fournier P (1995). Quality, cost and utilization of health services in developing countries. A longitudinal study in Zaire. Social Science & Medicine. 40(6): 743-753.
22. Jitta J. (2003).The availability of drugs: what does it mean in Ugandan primary care. Health Policy. 65: 167-179.
23. Khartoum Comprehensive Child Care Programme: a joint project of the Ministry of Health and Social Welfare, Democratic Republic of The Sudan, and The Khartoum Commission (Directorate General of Health Affairs). Funded by Save the Children Fund, UK. July 1987; 1987. http://www.who.int/medicines/services/ essmedicines-def/en/print.html; 2005
24. Lavy V, Germain J (1994). Quality and cost on health care choice developing countries. Living Standards Management Study Working Paper 105. World Bank, Washington D.C.
25. Litvack JI, Bodart C (1993). User fees plus quality equals improved access to health care: result of a field experiment in Cameroon. Social Science & Medicine; 37(3): 369-383.
26. Mariko M (2003). Quality of care and the demand for health services in Bamako, Mali: the specific roles of structural, process, and outcome components. Social Science & Medicines; 56: 1183-1196.
27. Meuwissen LE (2002). Problems of cost recovery implementation in district health care: a case study from Niger. Health Policy and Planning; 17(3): 304-313.
28. Ministry of Health (1990). Annual statistical report, Ministry of Health, Khartoum State-Sudan.
29. Ministry of Health. (1992). Annual statistical report, Ministry of Health, Khartoum State-Sudan.
30. Ministry of Health (1994). Annual statistical report, Ministry of Health, Khartoum State-Sudan.
31. Ministry of Health (1996). Annual statistical report, Ministry of Health, Khartoum State-Sudan.
32. Ministry of Health 1998). Annual statistical report, Ministry of Health, Khartoum State-Sudan.
33. Ministry of Health (2000). Annual statistical report, Ministry of Health, Khartoum State-Sudan;
34. Ministry of Health (2002). Annual statistical report, Ministry of Health, Khartoum State-Sudan.
35. Ministry of Health (2003). Annual statistical report, Ministry of Health, Khartoum State-Sudan.
36. Ministry of Health (2003). Health services in Khartoum State. Ministry of Health, Khartoum State-Sudan;
37. Mohamed, GK (2000) Management of Revolving Drug Fund: Experience of Khartoum State - Sudan. MSc. Dissertation, University of Bradford.
38. Murakami H, (2001). Revolving drug funds at front-line health facilities in Vientiane, Lao PDR. Health Policy and Planning; 16(1): 98-106.
39. Mwabu G, Wang'Ombe J (1995). User charges in Kenya: health service pricing reforms in Kenya, 1989-1993. A report on work in progress with support from the International Health Policy Programme. IHPP, Washington, D.C.
40. nd ed. West Hardford, CT: Kumarian Press.
41. Revolving Drug Fund (2002). Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
42. Revolving Drug Fund (1996). Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
43. Revolving Drug Fund (1997). Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
44. Revolving Drug Fund (1998).Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
45. Revolving Drug Fund (1999). Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
46. Revolving Drug Fund (2000). Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
47. Revolving Drug Fund (2001). Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
48. Revolving Drug Fund (2003). Annual report. RDF, Ministry of Health, Khartoum State-Sudan.
49. Revolving Drug Fund (1998). RDF operational manual, Ministry of Health, Khartoum - Sudan.
50. Uzochukwu BS (2002). Effect of the Bamako-initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria. Health Policy and Planning; 17(4): 378-383.
51. van der Geest S (2000). User fees and drugs: what did the health reforms in Zambia achieve? Health Policy and Planning. 15(1): 59-65.
52. World Health Organisation (2005) Essential medicines [online]. Available at: http://www.who.int/medicines/services/essmedicines-def/en/print.html. [Accessed December 2005].
53. Yazbeck A, Leighton C (1995). Does cost recovery for curative care affect preventive care utilization? Health Policy and Planning; 10(3):296-300.